It is validated that circ-ITCH resists miR-7, miR-17, and miR-214, while upregulating ITCH by blocking the Wnt/β-catenin pathway, thereby impeding the growth of NSCLC and esophageal squamous cell carcinoma (ESCC) [77, 78]. Here, ITCH is linked to non-small cell lung carcinoma.